Towards Healthcare
AI and ML in Drug Development Market to Surpass 26% CAGR in Asia Pacific Throu...

AI and ML in Drug Development Market Accelerates in 2025 with Oncology Leading at 36%

Rising advantages of AI and ML in the world are reducing timelines, cost-effective approaches in drug discovery and clinical trials are driving the global market. North America was dominant in the market due to technological advancements by using AI and ML, and increasing demand for personalized medicine. 

Content

  • Insight Code: 5809
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

Strong growth expected in AI and ML drug development market from 2025–2034, driven by tech advances and funding.

North America is currently leading the AI and ML in drug development market due to advancements in technologies, including AI-powered tools and platforms, rising demand for personalized medicines.

The AI and ML in drug development market includes seven segments, such as by phase of drug development, by technology type, by function/application, by deployment type, by therapeutic area, by end-user, and by region etc.

Some key players include Insilico Medicine, BenevolentAI, Exscientia, Recursion Pharmaceuticals, and Atomwise.

Key trends include rising demand for drug discovery and personalized medicine, growth in technological advancements, and innovation in clinical trials, novel molecules.

The future of AI/ML in drug development includes increased automation, more personalized therapies, faster drug discovery and development, and improved drug safety.

The benefits of ML frameworks for developers are to provide pre-built tools, libraries, and automation to support training, testing, and deploying models rapidly.
Any Questions